Local and international scientists have recorded a 27 percent resistance to anti-HIV drugs dolutegravir, exceeding levels initially observed during its trials. Before the World Health Organisation approved the drugs over a decade ago, resistance ranged from 3.9 percent to 8.6 percent, records show. Titled Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance

Related Keywords

Malawi , South Africa , Malawian , Bilaal Matola , Chifundo Chipungu , Pachawo Bisani , National Aids Commission , University Of The Witwatersrand , Malawi National , Kamuzu College Of Health Sciences , Treatment Programme , University Of Washington , World Health Organisation , Multidisciplinary Digital Publishing Institute , Public Health Adamson Muula , Virological Findings , Treatment Outcomes , Cases That Developed Dolutegravir Resistance , Kamuzu College , Health Sciences ,